The Net Margin of Coherus Oncology Inc (CHRS) is
398.43%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2025-12-31 |
398.43%
|
| 2024-12-31 |
10.68%
|
| 2023-12-31 |
-92.48%
|
| 2022-12-31 |
-138.29%
|
| 2021-12-31 |
-87.91%
|
| 2020-12-31 |
27.78%
|
| 2019-12-31 |
25.22%
|
| 2018-12-31 |
-14887.50%
|
| 2017-12-31 |
-66.96%
|
| Ticker |
Name |
Value |
|
ADMS
|
Adamas Pharmaceuticals Inc
|
-77.09%
|
|
HRTX
|
Heron Therapeutics Inc
|
-13.04%
|
|
TVTX
|
Travere Therapeutics, Inc.
|
-5.21%
|
|
EGRX
|
Eagle Pharmaceuticals Inc
|
11.24%
|
|
GILD
|
Gilead Sciences, Inc.
|
28.90%
|
|
MGNX
|
MacroGenics Inc
|
-49.91%
|
|
MNKD
|
MannKind Corporation
|
1.68%
|
|
MRNA
|
Moderna, Inc.
|
-145.16%
|
|
950160.KQ
|
Kolon TissueGene Inc
|
-3733.25%
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
31.41%
|
|
AMRN
|
Amarin Corporation PLC
|
-18.16%
|
|
CDMO
|
Avid Bioservices Inc
|
-100.60%
|
|
CRIS
|
Curis Inc
|
-80.29%
|
|
MDXG
|
MiMedx Group, Inc.
|
11.60%
|
|
ORGO
|
Organogenesis Holdings Inc.
|
6.56%
|
|
AMGN
|
Amgen Inc
|
20.98%
|
|
ENTA
|
Enanta Pharmaceuticals Inc
|
-125.36%
|
|
SVA
|
Sinovac Biotech Ltd
|
-22.29%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
32.94%
|
|
950200.KQ
|
Psomagen Inc
|
-5.04%
|
|
950220.KQ
|
Neoimmunetech Inc
|
-33533.01%
|
|
ANIK
|
Anika Therapeutics Inc
|
-9.64%
|
|
CPRX
|
Catalyst Pharmaceuticals, Inc.
|
36.39%
|
|
FLXN
|
Flexion Therapeutics Inc
|
-132.92%
|
|
TH.TO
|
Theratechnologies Inc
|
-9.67%
|
|
HRBR
|
Harbor Diversified Inc
|
0.04%
|
|
ICPT
|
Intercept Pharmaceuticals Inc
|
77.64%
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
-101.08%
|
|
ABBV
|
AbbVie Inc.
|
6.91%
|
|
AKBA
|
Akebia Therapeutics Inc
|
-2.26%
|
|
ATNX
|
Athenex Inc
|
-100.59%
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
-16748.03%
|
|
ESPR
|
Esperion Therapeutics, Inc.
|
-5.63%
|
|
MYGN
|
Myriad Genetics, Inc.
|
-44.38%
|
|
PGEN
|
Precigen, Inc.
|
-2588.21%
|
|
STRO
|
Sutro Biopharma Inc
|
-186.45%
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
-4612.13%
|